Cite
MLA Citation
Alex F. Herrera et al.. “Safety and activity of ibrutinib in combination with durvalumab in patients with relapsed or refractory follicular lymphoma or diffuse large B‐cell lymphoma.” American journal of hematology, vol. 95, no. 1, n.d., pp. 18–27. http://access.bl.uk/ark:/81055/vdc_100098071997.0x000041